IV

0 (0.0%)

3 (4.8%)

Aminoglycoside therapy

0.561

aminoglycoside therapy

268 (76.4%)

51 (79.7%)

no aminoglycoside therapy

83 (23.6%)

13 (20.3%)

Aminoglycoside therapy duration

<0.001

Mean (SD)

2.74 (1.74)

4.63 (2.35)

Median (Q1, Q3)

2.00 (1.00, 4.00)

5.00 (3.00, 6.50)

Min - Max

1.00 - 11.00

1.00 - 9.00